Page last updated: 2024-08-26

paxilline and sevoflurane

paxilline has been researched along with sevoflurane in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, J; Wang, X; Yao, Y	1

Other Studies

1 other study(ies) available for paxilline and sevoflurane

Article	Year
Sevoflurane inhibits growth factor-induced angiogenesis through suppressing Rac1/paxillin/FAK and Ras/Akt/mTOR. Future oncology (London, England), 2020, Volume: 16, Issue:22 Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Endothelial Cells; Fibroblast Growth Factor 2; Focal Adhesion Protein-Tyrosine Kinases; Humans; Paxillin; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; ras Proteins; Sevoflurane; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A	2020

Article

Year

Sevoflurane inhibits growth factor-induced angiogenesis through suppressing Rac1/paxillin/FAK and Ras/Akt/mTOR.

Future oncology (London, England), 2020, Volume: 16, Issue:22

Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Endothelial Cells; Fibroblast Growth Factor 2; Focal Adhesion Protein-Tyrosine Kinases; Humans; Paxillin; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; ras Proteins; Sevoflurane; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A

2020